Cite

HARVARD Citation

    Jackson, M. et al. (n.d.). High-dose palliative radiotherapy in metastatic castrate resistant prostate cancer – is it worthwhile? A single-centre outcome. Clinical oncology. pp. e6-. [Online]. 
  
Back to record